Centre Sanctions Funds From PMCares For Setting Up Vaccine-Testing Lab In Hyderabad

New Delhi : The Centre has sanctioned funds from the PMCares Fund for setting up a vaccine-testing laboratory here, Union Minister of State for Home G Kishan Reddy said on Saturday.

“I thank Hon’ble PM Shri Narendra Modi Ji for sanctioning funds for setting up of Vaccine Testing Lab at Hyderabad. A big step forward towards comprehensive development of pharma sector in Hyderabad, which will also boost production of Covid-9 vaccines,” Reddy, a Lok Sabha member from Secunderabad, tweeted.

The increased focus on vaccine production against the backdrop of the Covid-19 pandemic has necessitated more vaccine-testing laboratories in the country, Reddy said in a press release.

“At present, there are two vaccine-testing laboratories in the country — the Central Drug Laboratory at Kasauli and National Institute of Biologicals at Noida,” he said.

Funds have been released from the PM CARES Fund on March 6 for establishing two more such laboratories — one at National Centre for Cell Science, Pune, and the other at the National Institute of Animal Biotechnology, Hyderabad, under the Department of Biotechnology, he said.

The laboratory in Hyderabad is expected to commence operations in the next one month, he said. The setting up of the new laboratory is a big step towards the comprehensive development of the pharma sector in Hyderabad as the city is home to many pharma majors, Covid-19 vaccine production companies, and other R & D institutions, he said. It would also boost the production of Covid-19 vaccines, Reddy said.

  • Related Posts

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Phase 2 results for LB-102 showed statistically significant reductions in PANSS total score across all doses with onset by week 1 and sustained through study end, alongside low rates of…

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    After substandard drug manufacturing, the state drug firms are once again under the scanner of the central government for manufacture and sale of unapproved fixed dose combination (FDC) drugs which…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

    Stem cell therapy for autism illegal: NMC advisory

    Stem cell therapy for autism illegal: NMC advisory

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise

    NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise